You are here: Industry Insights > medicines

News List

EMA recommends 11 new medicines for approval following July meeting europeanpharmaceuticalreview
July 28, 2020
Dapivirine Vaginal Ring (dapivirine) and Blenrep (belantamab mafodotin) have been recommended for approval by the EMA’s CHMP, along with nine other medicines.
Eleven medicines backed for EU approval pharmatimes
July 27, 2020
The European Medicines Agency human medicines committee (CHMP) has backed eleven medicines for approval at its July 2020 meeting, including a medicine for use in countries outside the region and a novel treatment for multiple myeloma.
Novartis Launches Not-for-Profit Portfolio for Symptomatic Treatment of COVID-19 americanpharmaceuticalreview
July 24, 2020
Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC; LMIC) access affordable medicines to treat the major symptoms of COVID-19 – a critical need in the absence of a vaccine or curative treatment.
Novartis launches not-for-profit COVID-19 medications portfolio europeanpharmaceuticalreview
July 20, 2020
The portfolio will be offered to low- and lower-middle-income countries to help financially strained healthcare systems care for COVID-19 patients.
Novartis Launches Portfolio of Meds for COVID-19 Treatment contractpharma
July 17, 2020
Portfolio of 15 generic and OTC medicines from Sandoz will be sold at zero-profit to governments in eligible countries during the pandemic.
EMA issues opinion on nitrosamines in medicines europeanpharmaceuticalreview
July 14, 2020
The agency’s opinion will require companies to take measures to reduce nitrosamine impurities in medicines and carry out and action the results of risk assessments.
EMA finalises opinion on presence of nitrosamines in medicines expresspharma
July 13, 2020
Companies will be required to have appropriate control strategies to prevent or limit the presence of these impurities and, where necessary, improve their manufacturing processes.
Bill Gates calls for COVID-19 meds to go to people who need them, not ‘highest bidder’ expresspharma
July 13, 2020
Billionaire philanthropist Bill Gates called for COVID-19 drugs and an eventual vaccine to be made available to countries and people that need them most, not to the “highest bidder,” saying relying on market forces would prolong the deadly pandemic.
Novartis agrees to pay $678m to settle kickback charges in US pharmaceutical-technology
July 03, 2020
Novartis Pharmaceuticals has agreed to pay $678m to settle claims that the company made payments of kickback to doctors who prescribed its medicines, as well as Medicare patients.
IPA launches a digital campaign to ensure uninterrupted medicines supply during COVID-19 pandemic expresspharma
June 23, 2020
The campaign, called Mission Medicine- Delivering Life, aims to bring to light the human stories of the contributions made by people engaged in the pharma sector amidst the COVID-19 pandemic and subsequent lockdown.

Previous page 1 2 3 4 5 6 7 8 9 10 Next page